NCT06737497

Brief Summary

Retrograde intrarenal surgery (RIRS) is a well-established technique and is the first-line treatment option for upper urinary tract stones \<2cm. Currently, most ureteroscopic procedures are performed under general or epidural anesthesia, both of which are safe and feasible. In recent years, more and more studies have shown that retrograde intrarenal surgery (RIRS) under local anesthesia is safe and feasible. However, we can see that the current studies on RIRS under local anesthesia are mostly case reports, and there is a lack of systematic studies on the safety and effectiveness of RIRS under local anesthesia and its influencing factors. Therefore, the researchers hope to conduct a single-center prospective observational study to explore the safety, effectiveness and influencing factors of RIRS under local anesthesia, so as to optimize the surgical process of RIRS under local anesthesia, improve the surgical success rate and ensure surgical safety。

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
24mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
1.5 years until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Last Updated

March 7, 2025

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

December 12, 2024

Last Update Submit

March 6, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • pain score

    Visual Analogue Scale(VAS),The basic method is to use a moving ruler about 10cm long, with 10 scales on one side and "0" and "10" points on both ends, where 0 represents no pain and 10 represents the most unbearable pain.

    1 day after sugery

  • Operative time

    Surgery duration, minutes. From the insertion of the guide wire to the end of the indwelling ureteral stent.

    During surgery

Secondary Outcomes (3)

  • stone-free rate

    From enrollment to the end of treatment at 1 month

  • stone-free rate

    From enrollment to the end of treatment at 24 hours

  • Complication rate

    1 month after sugery

Interventions

retrograde Intrarenal Surgery ( RIRS ) under local anesthesia

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with upper urinary tract stones who are willing to undergo RIRS under local anesthesia.

You may qualify if:

  • Kidney stones or upper ureteral stones 1-4cm;
  • Age 18-70 years old;
  • American Society of Anesthesiologists(ASA) score Ⅰ, Ⅱ and Ⅲ;

You may not qualify if:

  • Surgical operations other than RIRS are required for patients with middle and lower ureteral calculi;
  • There are anatomical abnormalities, such as ureteral stenosis, urine flow diversion, ectopic kidney, horseshoe kidney, duplicate kidney, etc.
  • Severe heart, brain and lung diseases;
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, 510230, China

Location

MeSH Terms

Conditions

Urolithiasis

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Central Study Contacts

Guohua Zeng Ph.D and M.D

CONTACT

Wen Zhong Ph.D and M.D

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.D and M.D

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 17, 2024

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2028

Study Completion (Estimated)

July 1, 2028

Last Updated

March 7, 2025

Record last verified: 2024-12

Locations